# Assessment of Serum FAM19A5 Level in Egyptian Patients With Neuromyelitis Optica Spectrum Disorder

> **NCT05446701** · — · UNKNOWN · sponsor: **Assiut University** · enrollment: 120 (estimated)

## Conditions studied

- Assessment of Serum FAM19A5level in Egyptian Patients With NMOSD

## Interventions

- **DIAGNOSTIC_TEST:** serum level of FAM19A5

## Key facts

- **NCT ID:** NCT05446701
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-07-01
- **Primary completion:** 2023-09
- **Final completion:** 2024-04
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2022-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05446701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05446701, "Assessment of Serum FAM19A5 Level in Egyptian Patients With Neuromyelitis Optica Spectrum Disorder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05446701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*